Taiga Biotechnologies, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Taiga Biotechnologies, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2019).
SEC Form D · Jun 2019
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jun 2019
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Taiga Biotechnologies, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Brian C. Turner | President | Jun 2019 |
| James C. Kelly | Chief Financial Officer | Jun 2019 |
| Yosef C. Refaeli | Chief Executive Officer | Jun 2019 |
| Yosef L. Refaeli | Chief Executive Officer | Mar 2018 |
| Brian Curtis Turner | Executive officer | Jun 2015 |
| Yosef Curtis Refaeli | Executive officer | Jun 2015 |
| Brian C. Turner | President | Jun 2019 |
| Daniel C. Ritchie | Director | Jun 2019 |
| Earl L. Wright | Director | Jun 2019 |
| Stephen K. Erkenbrack | Director | Jun 2019 |
| Yosef C. Refaeli | Chief Executive Officer | Jun 2019 |
| Daniel L. Ritchie | Director | Mar 2018 |
| James C. Kelly | Director | Mar 2018 |
| Stephen K. ErkenBrack | Director | Mar 2018 |
| Yosef L. Refaeli | Chief Executive Officer | Mar 2018 |
| Brian Curtis Turner | Director | Jun 2015 |
| James Curtis Kelly | Director | Jun 2015 |
| Yosef Curtis Refaeli | Director | Jun 2015 |